Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-08-17

FDA Approved: LISINOPRIL — Supplemental Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for lisinopril from Camber Pharmaceuticals, Inc., for the generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lisinopril (Lisinopril)

Snippet

SUPPL AP for LISINOPRIL (LISINOPRIL)